Skip to main content

Aflac Value Stock - Dividend - Research Selection

Aflac

ISIN: US0010551028 , WKN: 853081

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

General Description

Aflac Incorporated (the Parent Company) was incorporated in 1973 under the laws of the state of Georgia. Aflac Incorporated is a general business holding company and acts as a management company, overseeing the operations of its subsidiaries by providing management services and making capital available. Its principal business is voluntary supplemental and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac), which operates in the United States (Aflac U.S.) and as a branch in Japan (Aflac Japan). Most of Aflac's policies are individually underwritten and marketed through independent agents. Aflac U.S. markets and administers group products through Continental American Insurance Company (CAIC), branded as Aflac Group Insurance. Our insurance operations in the United States and our branch in Japan service the two markets for our insurance business.

 

On December 2, 2016, we publicly announced that we will pursue the conversion of Aflac Japan from a branch structure to a subsidiary structure, with the subsidiary incorporated as a “Kabushiki Kaisha.” While the branch structure remains an acceptable legal form, the subsidiary structure has emerged as the more prevalent structure for both domestic and foreign companies operating in Japan. In addition, emerging global regulatory standards generally favor the subsidiary structure for foreign insurance and financial service companies. The adoption of this new organizational framework is expected to be tax-neutral and not to have a material impact on the daily operations of either Aflac Japan or Aflac U.S. as a result of this conversion. In addition, we expect to obtain enhanced flexibility in capital management and business development as a result of the conversion. We anticipate completion of the conversion in mid-2018.

 

Aflac offers voluntary insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. We continue to diversify our product offerings in both Japan and the United States. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells voluntary supplemental insurance products including products designed to protect individuals from depletion of assets (accident, cancer, critical illness/care, hospital indemnity, fixed-benefit dental, and vision care plans) and loss-of-income products (life and short-term disability plans).

 

We are authorized to conduct insurance business in all 50 states, the District of Columbia, several U.S. territories and Japan. Aflac Japan's revenues, including realized gains and losses on its investment portfolio, accounted for 71% of the Company's total revenues in 2016, compared with 70% in 2015 and 72% in 2014. The percentage of the Company's total assets attributable to Aflac Japan was 83% at both December 31, 2016 and 2015.

 

Reporting Segments

Aflac's insurance business consists of two reporting segments: Aflac Japan and Aflac U.S. Aflac Japan, which currently operates as a branch of Aflac, is the principal contributor to the Parent Company’s consolidated earnings. The conversion of Aflac Japan to a subsidiary structure is not expected to affect our segment reporting structure.

 

For information on our results of operations and financial information by segment, see MD&A and Note 2 of the Notes to the Consolidated Financial Statements in this report.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


15 New Reasons To Smile: Aflac Childhood Cancer Foundation Awards 2025 Child Life Grants

2025-09-15
NORTHAMPTON, MA / ACCESS Newswire / September 15, 2025 /Originally published on Aflac Newsroom The Aflac Childhood Cancer Foundation (ACCF) has announced recipients of their 2025 Child Life Grant awards benefitting 15 hospital programs that will help ...

Aflac's (NYSE:AFL) investors will be pleased with their splendid 237% return over the last five years

2025-09-15
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

AFLAC Inc. stock outperforms competitors on strong trading day

2025-09-11
AFLAC Inc. stock outperforms competitors on strong trading day

Aflac CEO Advice to Youth: Get Checked for Cancer for Your Health and Finances

2025-09-10
Most Americans are delaying or avoiding checkups and screenings that could save their lives. NORTHAMPTON, MA / ACCESS Newswire / September 10, 2025 /Originally published by The Atlanta Journal-Constitution By Dan Amos When my uncle John passed in ...

Aflac Voices - Audrey Boone Tillman: Advice for New Professionals

2025-09-09
By Audrey Boone Tillman, senior executive vice president, General Counsel NORTHAMPTON, MA / ACCESS Newswire / September 9, 2025 / Aflac Incorporated Photo: Audrey Boone Tillman, senior executive vice president, General Counsel Originally published ...

Zacks Industry Outlook Highlights Aflac, Trupanion and Globe Life

2025-09-08
Zacks highlights Aflac, Trupanion, and Globe Life as key stocks in the accident & health insurance industry, which faces pricing pressure but benefits from tech adoption, underwriting strength, and growing demand.

Aflac Incorporated (NYSE:AFL) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

2025-09-08
Aflac's (NYSE:AFL) stock up by 4.6% over the past three months. However, we decided to study the company's mixed-bag of...

Is Aflac Stock Underperforming the S&P 500?

2025-09-08
Aflac has significantly underperformed the S&P 500 in recent months and over the past year, and analysts remain cautious about the stock’s prospects.

AM Best Affirms Credit Ratings of Aflac Incorporated and Its Subsidiaries

2025-09-05
OLDWICK, N.J., September 05, 2025--AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "aa" (Superior) of Aflac Life Insurance Japan, Ltd. (Japan) (Aflac Japan), American Family Life Assurance Company of Columbus (Omaha, NE), American Family Life Assurance Company of New York (Albany, NY) and Continental American Insurance Company (Omaha, NE). These companies represent the life/health insurance subsidiaries of Aflac Incor

3 Accident & Health Insurance Stocks to Watch Amid Pricing Pressure

2025-09-05
Accident and Health Insurance stocks like AFL, TRUP and GL are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.